Kendrick Charles Morgan JR 4
4 · Elevance Health, Inc. · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
Elevance Health (ELV) EVP Kendrick Morgan Sells 3,196 Shares
What Happened
Kendrick Charles Morgan Jr., EVP & President, Commercial of Elevance Health (ELV), sold 3,196 shares in an open-market transaction on March 6, 2026. The reported weighted average sale price was $284.92, producing total proceeds of approximately $910,604. This was a sale (S) — commonly a routine disposition rather than a direct bullish signal.
Key Details
- Transaction date: 2026-03-06; Form 4 filed: 2026-03-09 (filed within the typical two-business-day reporting window).
- Quantity and price: 3,196 shares sold at a weighted average price of $284.92 (reported range $284.82–$285.08 across multiple trades).
- Proceeds: ~ $910,604.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnote: The sale was executed in multiple trades; the filer will provide, upon request, the breakdown of shares and prices.
- Transaction type: Open-market sale (code S).
Context
Sales by executives can be for many reasons (diversification, taxes, personal liquidity) and are not, by themselves, a clear signal about company prospects. Purchases generally carry more informational weight for investors. This filing discloses the sale details but does not explain the insider’s motivation.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-06$284.92/sh−3,196$910,604→ 11,791 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $284.82 to $285.08. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.